Indeed, treating MDA-MB 436 breast cancer cells with tamoxifen leads to the detection of an ERα36 modified heavy form of into the nucleus, which is associated with the induction the mammary cancer stem cell marker ALDH1 [53,104]. Here, ALDH1A1 is linked to breast cancer.